These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31485015)

  • 1. Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective.
    Sivanandan S; Jain K; Plakkal N; Bahl M; Sahoo T; Mukherjee S; Gupta YK; Agarwal R
    J Perinatol; 2019 Sep; 39(Suppl 1):20-30. PubMed ID: 31485015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: a multi-site randomized non-inferiority trial.
    Jain K; Nangia S; Ballambattu VB; Sundaram V; Sankar MJ; Ramji S; Vishnubhatla S; Thukral A; Gupta YK; Plakkal N; Sundaram M; Jajoo M; Kumar P; Jayaraman K; Jain A; Saili A; Murugesan A; Chawla D; Murki S; Nanavati R; Rao S; Vaidya U; Mehta A; Arora K; Mondkar J; Arya S; Bahl M; Utture A; Manerkar S; Bhat SR; Parikh T; Kumar M; Bajpai A; Sivanandan S; Dhawan PK; Vishwakarma G; Bangera S; Kumar S; Gopalakrishnan S; Jindal A; Natarajan CK; Saini A; Karunanidhi S; Malik M; Narang P; Kaur G; Yadav CP; Deorari A; Paul VK; Agarwal R
    J Perinatol; 2019 Sep; 39(Suppl 1):3-12. PubMed ID: 31485014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006069. PubMed ID: 17943881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.
    Singh N; Halliday HL; Stevens TP; Suresh G; Soll R; Rojas-Reyes MX
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010249. PubMed ID: 26690260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial.
    Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE
    J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
    Bancalari E
    Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767
    [No Abstract]   [Full Text] [Related]  

  • 9. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
    Ainsworth SB; Milligan DW
    Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.
    Ramanathan R
    J Perinatol; 2006 May; 26 Suppl 1(Suppl 1):S51-6; discussion S63-4. PubMed ID: 16625226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
    Soll RF; Blanco F
    Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
    Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 Aug; 8(8):CD000144. PubMed ID: 26301526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.